Top Markets
#1 CoW Protocol CoW Protocol +59.38%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Cysic Cysic +35.83%
#5 Walrus Walrus +25.94%
#6 Humanity Humanity +23.10%
#7 Enso Enso +17.07%
#8 Tutorial Tutorial +17.03%
#9 Velvet Velvet +17.00%
#10 Codatta Codatta +14.78%
Coin of the day
CoW Protocol CoW Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Classifica tra le azioni #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Prezzo delle azioni
$0.6
Ultima sincronizzazione: 2024-08-14
Capitalizzazione di mercato
$2.09M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
SG
Scambia ASLAN Pharmaceuticals Limited (ASLN)

Categoria

Healthcare
EPS per ASLAN Pharmaceuticals Limited (ASLN)
EPS al March 2024 TTM: $-7.92
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di ASLAN Pharmaceuticals Limited, l’EPS attuale della società (TTM) è $-7.92. Alla fine del 2022, la società aveva un EPS di $-14.72 un aumento rispetto a rispetto a quello del 2021, che era di $-10.64.
Storico EPS per ASLAN Pharmaceuticals Limited da 2014 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-7.92 -26.39%
2023 $-10.76 -26.90%
2022 $-14.72 38.35%
2021 $-10.64 14.16%
2020 $-9.32 -67.86%
2019 $-29.00 2.98%
2018 $-28.16 -13.94%
2017 $-32.72 372.83%
2016 $-6.92 -71.40%
2015 $-24.20 -79.00%
2014 $-115.24 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -318.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -450.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -272.98%
BE